Testing effectiveness (Phase 2)Study completedNCT01949090
What this trial is testing
Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older
Who this might be right for
Influenza
GlaxoSmithKline 363